Addus HomeCare Co. (NASDAQ:ADUS) Sees Significant Increase in Short Interest

Addus HomeCare Co. (NASDAQ:ADUSGet Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 503,800 shares, an increase of 11.5% from the December 31st total of 452,000 shares. Based on an average daily volume of 136,600 shares, the short-interest ratio is currently 3.7 days.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. Royal Bank of Canada reissued an “outperform” rating and issued a $136.00 target price on shares of Addus HomeCare in a report on Thursday, November 14th. Stephens raised their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 6th. Oppenheimer raised their price objective on Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Macquarie reiterated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research note on Monday, November 4th. Finally, JMP Securities began coverage on Addus HomeCare in a research note on Monday, December 16th. They set an “outperform” rating and a $150.00 target price on the stock. One analyst has rated the stock with a sell rating, nine have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $134.22.

Get Our Latest Analysis on ADUS

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the sale, the chief executive officer now directly owns 141,897 shares in the company, valued at $17,476,034.52. This represents a 8.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the sale, the executive vice president now owns 10,217 shares in the company, valued at $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 39,750 shares of company stock worth $4,930,750 over the last ninety days. Insiders own 4.60% of the company’s stock.

Institutional Trading of Addus HomeCare

A number of large investors have recently added to or reduced their stakes in the company. Connor Clark & Lunn Investment Management Ltd. acquired a new position in Addus HomeCare during the 3rd quarter valued at about $1,622,000. JPMorgan Chase & Co. grew its holdings in Addus HomeCare by 10.2% during the third quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company’s stock worth $24,371,000 after acquiring an additional 16,997 shares during the period. Harbor Capital Advisors Inc. boosted its position in Addus HomeCare by 127.7% during the third quarter. Harbor Capital Advisors Inc. now owns 64,311 shares of the company’s stock worth $8,555,000 after purchasing an additional 36,071 shares in the last quarter. Principal Financial Group Inc. boosted its position in Addus HomeCare by 17.5% during the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after purchasing an additional 75,409 shares in the last quarter. Finally, Quest Partners LLC lifted its position in shares of Addus HomeCare by 4,087.0% in the third quarter. Quest Partners LLC now owns 11,263 shares of the company’s stock valued at $1,498,000 after acquiring an additional 10,994 shares in the last quarter. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Stock Down 0.9 %

ADUS stock opened at $125.16 on Monday. Addus HomeCare has a twelve month low of $85.94 and a twelve month high of $136.72. The stock has a market cap of $2.27 billion, a P/E ratio of 28.64, a PEG ratio of 1.63 and a beta of 1.00. The business’s 50-day moving average price is $126.86 and its 200-day moving average price is $127.35.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last posted its quarterly earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. During the same period in the previous year, the firm earned $1.03 EPS. The firm’s revenue was up 7.1% compared to the same quarter last year. On average, equities research analysts expect that Addus HomeCare will post 4.58 earnings per share for the current fiscal year.

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Read More

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.